CardiologyOnline.net

Cardiology Xagena

Search results for "Acute coronary syndromes"

The Aggrastat to Zocor study, or A to Z study, phase Z has assessed whether early intensive Simvastatin ( Zocor ) treatment had advantages over a delayed conservative Simvastatin strategy in ACS ( ac ...


An analysis by researchers from the Duke Clinical Research Institute has shown that patients hospitalized for non–ST-segment elevation acute coronary syndromes ( NSTE ACS ) and treated with Morphine ...


Aspirin and Clopidogrel ( Plavix ) are platelet antiaggregant drugs widely used and proven to be effective in the treatment of an acute coronary syndrome ( ACS ). High-risk patients with non-ST segme ...


Very low LDL cholesterol levels appear to be safe for heart patients on statin therapies. " There was no apparent safety concern for patients whose resultant LDL on intensive therapy was lower tha ...


A review of more than 56,000 cases of acute coronary syndromes reveals that older patients are less likely to receive treatment recommended by guidelines, even though they benefit as much or more than ...


A study, published in the JAMA, showed that high-risk patients with acute coronary syndromes ( ACS ) treated with an early revascularization strategy and Enoxaparin ( Clexane / Lovenox ) or unfractio ...


A prospective observational analysis, coordinated by the DCRI ( Duke Clinical Research Institute ), in 387 US hospitals of 30,136 patients from the CRUSADE database has found that patients with NSTE ...


In healthy volunteers, the equivalent of two cups of coffee reduced the body's ability to boost blood flow to the heart muscle in response to exercise, and the effect was stronger when the participant ...


The ACUITY ( Acute Catheterization and Urgent Intervention Triage strategy ) trial has assessed the potential of the injectable anti-clotting medicine Bivalirudin ( Angiomax ) in patients experiencing ...


Patients with acute coronary syndromes ( ACS ), such as heart attack and recent-onset chest pain, remain at considerable risk of experiencing further serious cardiovascular problems despite improvemen ...


Patients with depression appear to have an impaired ability to recover their heart rate variability ( HRV ) following acute coronary syndromes, a factor that could increase their risk of coronary deat ...


Drug-eluting stents ( DES ) are extremely effective devices to prevent restenosis following angioplasty. Yet, since last year, there is some debate and persistent uncertainty regarding the long term s ...


Recent changes in the recommended treatments used for patients hospitalized for acute coronary syndromes are associated with reductions in the rates of heart failure, stroke, myocardial infarction and ...


Continuing to smoke following a myocardial infarction is the most powerful predictor for recurrent cardiac events among survivors age 35 years or younger. In particular, patients who continue to smok ...


Prasugrel ( Efient, Effient ), a new antiplatelet agent that provides higher levels of platelet inhibition than current standard therapies, could provide more consistent protection from ischemic event ...